Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 14Gynecologic 4Sarcoma 2Lymphoid 2Thoracic 1Other hematologic neoplasm 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, Follicular 1Heart Defects, Congenital 1Coma 1Cerebrovascular Disorders 1Brain Injuries, Traumatic 1

Interventions

Cyclophosphamide 886Rituximab 864Vincristine 382Etoposide 381fludarabine 342Cytarabine 341Doxorubicin 340fludarabine phosphate 319Methotrexate 310Dexamethasone 283Prednisone 282Lenalidomide 245Filgrastim 228Melphalan 200Peripheral Blood Stem Cell Transplantation 184Radiotherapy 175Whole-Body Irradiation 172Busulfan 165Mycophenolic Acid 161venetoclax 158Bendamustine Hydrochloride 158Granulocyte Colony-Stimulating Factor 151Tacrolimus 145ibrutinib 144Bortezomib 138obinutuzumab 125Gemcitabine 113Cyclosporine 110Antilymphocyte Serum 103Carmustine 100

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Enhanced Recovery After Surgery × Lymphoid × Clear all
NCT06241482 2025-03-04

Safety and Efficacy of Enhanced Recovery After Surgery in Neurocritical Care

Shanghai 6th People's Hospital

Phase NA Recruiting
80 enrolled
Lymphoid

Brain Injuries, Traumatic, Cerebrovascular Disorders, Coma, Lymphoma, Follicular

NCT05665712 2023-10-05

PERCS

University of Alberta

Completed
483 enrolled
LymphoidOther hematologic neoplasm

Heart Defects, Congenital, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡